Psilocybin-assisted therapy is legal in three states, but access has so far been limited and expensive.
Category: Psychedelic and Hallucinogenic Drugs
-
Texas OK’s $50 Million for Ibogaine Research
The state’s governor signed legislation to allow clinical trials of a psychedelic drug that shows promise for veterans in treating addiction and post-traumatic stress disorder.
-
Amanda Feilding, Countess Who Drilled a Hole in Her Head, Dies at 82
She was ridiculed for drilling a hole in her skull to increase blood flow, but her foundation’s research into the therapeutic use of counterculture drugs proved visionary.
-
On the Campaign Trail, Elon Musk Juggled Drugs and Family Drama
As Mr. Musk entered President Trump’s orbit, his private life grew increasingly tumultuous and his drug use was more intense than previously known.
-
How an Activist Group Helped Torpedo MDMA Therapy
The fallout from the F.D.A.’s rejection of a new treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.
-
Can Psychedelics Help CEOs Boost Their Leadership Skills?
A growing cottage industry is dedicated to the theory that mind-altering drugs can improve business leadership.
-
Mike Tyson’s Inspiration for Jake Paul Fight: Smoking Toad Venom.
The former heavyweight champion told Interview magazine his experiences with a hallucinogenic poison played a role in his agreeing to fight the YouTuber Jake Paul.
-
Three MDMA Studies Are Retracted by Scientific Journal
The psychedelic treatment, for PTSD, was rejected last week by government regulators.
-
F.D.A. Declines to Approve MDMA Therapy, Seeking More Study
The agency said there was insufficient data to allow the use of a treatment for PTSD that involves the drug known as Ecstasy, according to the company seeking approval.
-
Veterans and Lawmakers Lobby for Approval of MDMA Therapy
The F.D.A. is poised to rule on the therapeutic use of the club drug Ecstasy, a potential watershed moment in the nascent field of psychedelic medicine.
-
FDA Panel Rejects Use of MDMA for Treatment of PTSD
An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.